Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea
July 18, 2023 07:40 ET
|
Incannex Healthcare
Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening Phase 2/3 clinical trial investigating IHL-42X for treatment of OSA.The Phase 2/3...
PAP Devices Market to Be Worth $6.63 Billion by 2030 — Exclusive Report by Meticulous Research®
June 28, 2023 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, June 28, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘PAP Devices Market by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease...
Sleep Apnea Devices Market Size is projected to reach USD 6.79 billion by 2030, growing at a CAGR of 6.30%: Straits Research
June 15, 2023 10:10 ET
|
Straits Research
New York, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The abnormal breathing pattern that a person experiences while they are asleep is a sign of the sleeping disorder known as sleep apnea....
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023 09:00 ET
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023 09:00 ET
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
UAE Sleep Apnea Devices Market Report 2023: Rise in Clinical Awareness About Sleep Apnea Fuels Growth
March 02, 2023 06:18 ET
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "UAE Sleep Apnea Devices Market, By Type (Therapeutic v/s Diagnostic), By Indication (Obstructive Sleep Apnea v/s Central Sleep Apnea), By End User...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
January 26, 2023 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
January 26, 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the...
RemSleep Holdings Inc. Issues Letter to Shareholders
January 06, 2023 14:09 ET
|
RemSleep Holdings, Inc.
Tampa, FL, Jan. 06, 2023 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep...
Global Sleep Apnea Devices Market Report 2022: Featuring Koninklijke Philips, Oventus, Cadwell Industries, ResMed & More
December 29, 2022 06:03 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Global Sleep Apnea Devices Market By device type, By end user & By region-Forecast Analysis 2022-2028" report has been added to ...